Work

21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology

Year: 2017

Type: article

Source: Breast Cancer Research and Treatment

DOI: 10.1007/s10549-017-4550-8

Authors: Eleftherios P. Mamounas, Gong Tang, Soonmyung Paik, Frederick L. Baehner, Qing Liu, Jong-Hyeon Jeong, S. Rim Kim, Steven M. Butler, Farid Jamshidian, Diana B. Cherbavaz, Amy P. Sing, Steven Shak, Thomas B. Julian, Barry C. Lembersky, D. Lawrence Wickerham, Joseph P. Costantino, Norman Wolmark

Institutions: Orlando Health, University of Florida Health, NRG Oncology, NSABP Foundation, University of Pittsburgh, Yonsei University, Genomic Health (United States), Allegheny General Hospital

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: G1291646684, NRG Oncology NCORP Research Base, NRG Oncology Network Group Operations Center, G467764903, G9000033067

OpenAlex ID: W2768080316

FWCI: 1.011

Cites: 22

Cited by: 55

Related to: 10